Ibrahim El‐Serafi
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 9
- CAR-T cell therapy research 3
-
- Pharmacogenetics and Drug Metabolism 8
- Co-authors
- Moustapha Hassan (18 shared papers)Manuchehr Abedi‐Valugerdi (7 shared papers)Fei Ye (2 shared papers)Mamoun Muhammed (2 shared papers)Åsa Barrefelt (2 shared papers)Jonas Mattsson (13 shared papers)Heba Asem (2 shared papers)Khalid M. Abu–Salah (2 shared papers)
- Journals
- PLoS ONE (3 papers)International Journal of Molecular Sciences (2 papers)Scientific Reports (1 paper)Differentiation (1 paper)Blood (1 paper)
- Partner nations
- SwedenUnited Arab EmiratesEgypt
In The Last Decade
Ibrahim El‐Serafi
29 papers receiving 584 citations
Peers
Comparison fields: 5 of 88
- Biomaterials 147
- Pharmacology 56
- Oncology 158
- Rehabilitation 31
- Biomedical Engineering 178
Countries citing papers authored by Ibrahim El‐Serafi
This map shows the geographic impact of Ibrahim El‐Serafi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim El‐Serafi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim El‐Serafi more than expected).
Fields of papers citing papers by Ibrahim El‐Serafi
This network shows the impact of papers produced by Ibrahim El‐Serafi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim El‐Serafi. The network helps show where Ibrahim El‐Serafi may publish in the future.
Co-authors
The 25 scholars most cited alongside Ibrahim El‐Serafi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 176 | |
| 2 | 2021 | 76 | |
| 3 | 2023 | 38 | |
| 4 | 2017 | 32 | |
| 5 | 2015 | 30 | |
| 6 | 2016 | 26 | |
| 7 | 2015 | 24 | |
| 8 | 2022 | 23 | |
| 9 | 2022 | 21 | |
| 10 | 2014 | 19 | |
| 11 | 2012 | 16 | |
| 12 | 2017 | 16 | |
| 13 | 2018 | 11 | |
| 14 | 2013 | 11 | |
| 15 | 2019 | 10 | |
| 16 | 2024 | 8 | |
| 17 | 2022 | 8 | |
| 18 | 2017 | 8 | |
| 19 | 2014 | 8 | |
| 20 | 2013 | 7 |
About Ibrahim El‐Serafi
Ibrahim El‐Serafi is a scholar working on Oncology, Pharmacology, Molecular Biology, Hematology and Cancer Research, having authored 31 papers that have together received 593 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (8 papers), Hematopoietic Stem Cell Transplantation (7 papers), Carcinogens and Genotoxicity Assessment (4 papers), CAR-T cell therapy research (3 papers), Hormonal Regulation and Hypertension (3 papers), Immune Cell Function and Interaction (3 papers), Bone Tissue Engineering Materials (3 papers) and Wound Healing and Treatments (3 papers). The work is most often cited by research in Biomaterials (147 citations), Pharmacology (56 citations), Oncology (158 citations), Rehabilitation (31 citations) and Biomedical Engineering (178 citations). Ibrahim El‐Serafi has collaborated with scholars based in Sweden, United Arab Emirates and Egypt. Frequent co-authors include Moustapha Hassan, Manuchehr Abedi‐Valugerdi, Fei Ye, Mamoun Muhammed, Åsa Barrefelt, Jonas Mattsson, Heba Asem, Khalid M. Abu–Salah, Ahmed T. El‐Serafi and Salman Alrokayan. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences, Scientific Reports, Differentiation and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.